Dog Degenerative Myelopathy: Welfare and Management

Degenerative myelopathy is a progressive neurological disease in dogs causing gradual paralysis that requires compassionate management and quality of life assessment.

Key Facts

Degenerative myelopathy is caused by a mutation in the SOD1 gene found in many breeds
German Shepherds, Corgis and Boxers have highest prevalence but 140+ breeds are affected
The condition causes progressive paralysis that starts in the hindlimbs and advances forward
Dogs feel no pain from the nerve degeneration itself but secondary complications cause discomfort
Physiotherapy and exercise can slow functional decline and maintain muscle mass and mobility
Wheelchairs and mobility aids maintain quality of life during middle stages
The terminal stage involving front limb weakness and respiratory failure requires timely end-of-life decisions

Welfare Considerations

Degenerative myelopathy presents a profound welfare challenge because dogs lose physical function while remaining mentally alert and engaged with their world. The progressive nature of the condition means owners must continuously reassess whether the current stage represents acceptable quality of life. Dogs in the middle stages with hindlimb paralysis, supported by wheelchairs and dedicated nursing care, can maintain excellent welfare. However, the terminal stages when dogs lose front limb function and cannot be positioned or moved without assistance represent a point at which dignified quality of life cannot be maintained. Support for owners navigating these decisions is an important welfare service.

What You Can Do

Pursue genetic testing before breeding dogs from affected breeds or lines
Learn physiotherapy exercises from a canine rehabilitation specialist to slow decline
Invest in a properly fitted dog wheelchair to maintain mobility in middle stages
Implement skin care protocols to prevent pressure sores in dogs with reduced mobility
Keep affected dogs mentally stimulated through enrichment activities they can still access
Work with your vet to establish quality of life criteria for end-of-life decisions
Connect with degenerative myelopathy support communities for owner guidance